Sarah Kraus

2.5k total citations
69 papers, 1.6k citations indexed

About

Sarah Kraus is a scholar working on Oncology, Genetics and Pharmacology. According to data from OpenAlex, Sarah Kraus has authored 69 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Genetics and 14 papers in Pharmacology. Recurrent topics in Sarah Kraus's work include Inflammatory mediators and NSAID effects (11 papers), Genetic factors in colorectal cancer (10 papers) and Estrogen and related hormone effects (10 papers). Sarah Kraus is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Genetic factors in colorectal cancer (10 papers) and Estrogen and related hormone effects (10 papers). Sarah Kraus collaborates with scholars based in Israel, United States and Canada. Sarah Kraus's co-authors include Nadir Arber, Rony Seger, Zvi Naor, Zvi Fishelson, Shiran Shapira, David Bonfil, Dana Chuderland, Dina Kazanov, Osnat Bohana‐Kashtan and Michael Kirschfink and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Sarah Kraus

67 papers receiving 1.6k citations

Peers

Sarah Kraus
Zhenbo Zhang China
KyuBum Kwack South Korea
Wojciech Jóźwicki Poland
Manabu Nakashima Japan
Shinji Iwasaki Japan
Viqar Syed United States
Jean‐Philippe Salier France
Kenta Masuda Japan
Kwan‐Hyuck Baek South Korea
Yasufumi Goto Japan
Zhenbo Zhang China
Sarah Kraus
Citations per year, relative to Sarah Kraus Sarah Kraus (= 1×) peers Zhenbo Zhang

Countries citing papers authored by Sarah Kraus

Since Specialization
Citations

This map shows the geographic impact of Sarah Kraus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Kraus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Kraus more than expected).

Fields of papers citing papers by Sarah Kraus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Kraus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Kraus. The network helps show where Sarah Kraus may publish in the future.

Co-authorship network of co-authors of Sarah Kraus

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Kraus. A scholar is included among the top collaborators of Sarah Kraus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Kraus. Sarah Kraus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kraus, Sarah, et al.. (2025). Macrophage Responses to Multicore Encapsulated Iron Oxide Nanoparticles for Cancer Therapy. ACS Omega. 10(4). 3535–3550. 2 indexed citations
3.
Markakis, Ioannis, et al.. (2024). A Validated Methodological Approach to Prove the Safety of Clinical Electromagnetic Induction Systems in Magnetic Hyperthermia. Cancers. 16(3). 621–621. 6 indexed citations
4.
Kraus, Sarah, et al.. (2022). Self-regulating novel iron oxide nanoparticle-based magnetic hyperthermia in swine: biocompatibility, biodistribution, and safety assessments. Archives of Toxicology. 96(9). 2447–2464. 6 indexed citations
5.
Kraus, Sarah, et al.. (2021). Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model. Frontiers in Oncology. 11. 761045–761045. 10 indexed citations
6.
Schulze, Markus, Christiane B. Knobbe‐Thomsen, Sarah Kraus, et al.. (2015). Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness. Oncogene. 35(24). 3163–3177. 13 indexed citations
7.
Shamai, Sivan, et al.. (2015). CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome. PLoS ONE. 10(9). e0134469–e0134469. 5 indexed citations
8.
Kaplan, Ilana, Ari Leshno, Menachem Moshkowitz, et al.. (2015). Association of CD24 and the adenomatous polyposis coli gene polymorphisms with oral lichen planus. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 120(3). 378–385. 4 indexed citations
9.
Kraus, Sarah, et al.. (2014). Recent advances in personalized colorectal cancer research. Cancer Letters. 347(1). 15–21. 48 indexed citations
10.
Boursi, Ben, Tal Sella, Eliezer Liberman, et al.. (2013). The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews. European Journal of Cancer. 49(17). 3680–3685. 33 indexed citations
11.
Kraus, Sarah, et al.. (2012). COX-2 Active Agents in the Chemoprevention of Colorectal Cancer. Recent results in cancer research. 191. 95–103. 23 indexed citations
12.
Kazanov, Dina, et al.. (2011). Novel approach to abuse the hyperactive K-Ras pathway for adenoviral gene therapy of colorectal cancer. Experimental Cell Research. 318(2). 160–168. 6 indexed citations
13.
Shapira, Shiran, et al.. (2010). Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins. Expert Opinion on Investigational Drugs. 19(sup1). S67–S77. 14 indexed citations
14.
Kraus, Sarah & Nadir Arber. (2009). Screening for colorectal cancer, where are we now?. European Journal of Cancer. 45. 422–424. 1 indexed citations
15.
Hall, Michael J., Eliezer Liberman, Eyal Sagiv, et al.. (2009). Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Annals of Oncology. 20(9). 1517–1521. 8 indexed citations
16.
Kraus, Sarah, Zvi Naor, & Rony Seger. (2005). Gonadotropin-releasing hormone in apoptosis of prostate cancer cells. Cancer Letters. 234(2). 109–123. 41 indexed citations
17.
Kraus, Sarah & Rony Seger. (2004). Determination of ERK Activity: Antiphospho-ERK Antibodies, In Vitro Phosphorylation, and In-Gel Kinase Assay. Humana Press eBooks. 250. 29–48. 5 indexed citations
18.
19.
Jurianz, K., Stefanie Ziegler, Helena Garcia Schüler, et al.. (1999). Complement resistance of tumor cells: basal and induced mechanisms. Molecular Immunology. 36(13-14). 929–939. 173 indexed citations
20.
Liel, Yair, Sarah Kraus, Joseph Levy, & Shraga Shany. (1992). Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).. Endocrinology. 130(5). 2597–2601. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenbo Zhang Breakdown of academic impact, for papers by KyuBum Kwack Breakdown of academic impact, for papers by Wojciech Jóźwicki Breakdown of academic impact, for papers by Manabu Nakashima Breakdown of academic impact, for papers by Shinji Iwasaki Breakdown of academic impact, for papers by Viqar Syed Breakdown of academic impact, for papers by Jean‐Philippe Salier Breakdown of academic impact, for papers by Kenta Masuda Breakdown of academic impact, for papers by Kwan‐Hyuck Baek Breakdown of academic impact, for papers by Yasufumi Goto
Rankless by CCL
2026